Hes 1dh wild type slightly methalayted

I appreciate you sharing this information, but I need to clarify what I'm seeing so I can give you the most helpful response.

You've mentioned "He's 1dh wild type slightly methylated" — this appears to be a genetic or molecular finding, possibly related to:

• IDH1 (Isocitrate Dehydrogenase 1) status in a tumor
• Methylation patterns in cancer cells

However, I'm missing some critical context to interpret this meaningfully:

What I need to know:

1. What type of cancer are we discussing? (e.g., glioma, acute myeloid leukemia, cholangiocarcinoma, etc.)
2. Is this from a pathology report, genetic test, or molecular profiling?
3. Are there other test results or findings you can share?
4. What is the patient's current treatment status?

Why this matters: IDH1 wild-type status and methylation patterns have VERY different clinical meanings depending on the cancer type. For example:

• In glioblastoma, IDH1 wild-type vs. mutant status dramatically affects prognosis and treatment
• In acute myeloid leukemia (AML), IDH mutations influence treatment decisions
• In cholangiocarcinoma, IDH mutations open specific targeted therapy options

---

Can you share:

• The complete pathology or molecular report (or upload it)?
• What type of cancer this is?
• Any other test results mentioned alongside this finding?

Once I have that context, I can give you a proper educational interpretation with specific questions to ask the care team.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.